Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;4(2):265-80.
doi: 10.2217/bmm.10.12.

Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury

Prasad Devarajan  1
Affiliations
Review

Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury

Prasad Devarajan. Biomark Med. 2010 Apr.

Abstract

Acute kidney injury (AKI) is a common and serious condition, the diagnosis of which depends on serum creatinine measurements. Unfortunately, creatinine is a delayed and unreliable indicator of AKI. The lack of early biomarkers has crippled our ability to translate promising experimental therapies to human AKI. Fortunately, understanding the early stress response of the kidney to acute injuries has revealed a number of potential biomarkers. The discovery, translation and validation of neutrophil gelatinase-associated lipocalin, arguably the most promising novel AKI biomarker, are reviewed in this article. Neutrophil gelatinase-associated lipocalin is emerging as an excellent standalone troponin-like biomarker in the plasma and urine for the prediction of AKI, monitoring clinical trials in AKI and for the prognosis of AKI in several common clinical scenarios.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Clinical continuum of acute kidney injury
The figure is color-coded to identify the various stages, and the biomarkers that correspond to them. AKI: Acute kidney injury; GFR: Glomerular filtration rate; NGAL: Neutrophil gelatinase-associated lipocalin.
Figure 2
Figure 2. Pathophysiologic continuum of acute kidney injury
The figure is color-coded to correspond to the various stages identified in Figure 1. AKI: Acute kidney injury.
Figure 3
Figure 3. The cellular role of neutrophil gelatinase-associated lipocalin may be dependent on the type of molecule it is complexed with
Apo-NGAL: Neutrophil gelatinase-associated lipocalin that is devoid of siderophore or iron; ECM: Extracellular matrix.
Figure 4
Figure 4. Plasma neutrophil gelatinase-associated lipocalin levels measured by Triage® neutrophil gelatinase-associated lipocalin device at various time points after cardiopulmonary bypass in subjects with no acute kidney injury (N), or with acute kidney injury (R, I or F) stratified by RIFLE criteria
NGAL: Neutrophil gelatinase-associated lipocalin. Post hoc analysis of data from reference [92].
Figure 5
Figure 5. Urine neutrophil gelatinase-associated lipocalin levels measured by ARCHITECT® analyzer at various time points after cardiopulmonary bypass in subjects with no acute kidney injury (N), or with acute kidney injury (R, I or F) stratified by RIFLE criteria
NGAL: Neutrophil gelatinase-associated lipocalin. Post hoc analysis of data from [93].
See this image and copyright information in PMC

References

Bibliography

    1. Murray PT, Devarajan P, Level AS, et al. A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol. 2008;3:864–868. Novel approach to clinical staging of acute kidney injury (AKI) - PubMed
    1. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17:1503–1520. Comprehensive review of the pathophysiologic mechanisms that underlie AKI. - PubMed
    1. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:127–132. - PubMed
    1. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest. 2008;68:89–94. - PMC - PubMed
    1. Devarajan P. Neutrophil gelatinase-associated lipocalin – an emerging troponin for kidney injury. Nephrol Dial Transplant. 2008;23(12):3737–3743. Comprehensive review of neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker of AKI, in comparison with other novel biomarkers. - PMC - PubMed

Website

    1. US FDA. Challenges and Opportunities Report. Mar, 2004. www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/Critica....

Publication types

MeSH terms